QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosisspecific antigens

European Respiratory Journal

Volumn 47, Issue 2, 2016, Pages 660-664

  Losi, Monica ^a   Knights, Ashley J ^b   Mariani, Francesca ^c   Altieri, Alfonso M ^d   Paone, Gregorino ^e   Loxton, Andre G ^f   Chegou, Novel N ^f   Kenneth, John ^g   Alma, Mario G ^d   Colizzi, Vittorio ^a   Walzl, Gerhard ^f   Saltini, Cesare ^a   Boyle, Jeff ^b   Amicosante, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b QIAGEN North America   (United States)

^c CNR   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF STELLENBOSCH   (South Africa)

^g ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIAL PROTEIN; GAMMA INTERFERON; MYCOBACTERIUM TUBERCULOSIS SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; MYCOBACTERIUM TUBERCULOSIS ANTIGENS; RV3425 PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ADULT; AMINO ACID SEQUENCE; ANTIGENICITY; AUSTRALIA; BULGARIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ITALY; LETTER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INDIA; INTERFERON GAMMA RELEASE ASSAY; MIDDLE AGED; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PROCEDURES; SEROLOGY; SOUTH AFRICA; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; AUSTRALIA; BACTERIAL PROTEINS; BULGARIA; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; INDIA; INTERFERON-GAMMA RELEASE TESTS; ITALY; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SOUTH AFRICA; TUBERCULOSIS; YOUNG ADULT;

EID: 84958035622     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01015-2015     Document Type: Letter

References (15)

1. Whitworth HS, Aranday-Cortes E, Lalvani A. Biomarkers of tuberculosis: a research roadmap. Biomark Med 2013; 7: 349-362.
2. Redelman-Sidi G, Sepkowitz KA. IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. Am J Respir Crit Care Med 2013; 188: 422-431.
3. Sester M, Sotgiu G, Lange C, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011; 37: 100-111.
4. Arlehamn CS, Sidney J, Henderson R, et al. Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ). J Immunol 2012; 188: 5020-5031.
5. Wang S, Chen J, Zhang Y, et al. Mycobacterium tuberculosis region of difference (RD) 2 antigen Rv1985c and RD11 antigen Rv3425 have the promising potential to distinguish patients with active tuberculosis from M. bovis BCG-vaccinated individuals. Clin Vaccine Immunol 2013; 20: 69-76.
6. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161: 1376-1395.
7. Cappelli G, Volpe E, Grassi M, et al. Profiling of Mycobacterium tuberculosis gene expression during human macrophage infection: upregulation of the alternative sigma factor G, a group of transcriptional regulators, and proteins with unknown function. Res Microbiol 2006; 157: 445-455.
8. Seghrouchni F, Contini S, Markova R, et al. Design of immunogenic peptides from M. tuberculosis genes expressed during macrophage infection. Tuberculosis 2009; 89: 210-217.
9. Amicosante M, Mariani F, Colizzi V, et al. Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom. European Patent Register publication number EP2595645. https://register.epo.org/application?number=EP11754756
10. Nikolova M, Markova R, Drenska R, et al. Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagn Microbiol Infect Dis 2013; 75: 277-281.
11. Metcalfe JZ, Cattamanchi A, McCulloch CE, et al. Test variability of the Quanti FERON-TB Gold In-Tube assay in clinical practice. Am J Respir Crit Care Med 2013; 187: 206-211.
12. Karosiene E, Lundegaard C, Lund O, et al. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions. Immunogenetics 2012; 64: 177-186.
13. Mohan T, Bhatnagar S, Gupta DL, et al. Current understanding of HIV-1 and T-cell adaptive immunity: progress to date. Microb Pathog 2014; 73: 60-69.
14. Chiacchio T, Petruccioli E, Vanini V, et al. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. J Infect 2014; 69: 533-545.
15. Joshi M, Monson TP, Joshi A, et al. IFN-γ release assay conversions and reversions. Challenges with serial testing in U.S. health care workers. Ann Am Thorac Soc 2014; 11: 296-302.